US Ambassador affirms RCSI Medical University of Bahrain's role in advancing Medical and Academic partnerships with US
The Royal College of Surgeons in Ireland (RCSI) – Medical University of Bahrain welcomed yesterday His Excellency Steven C. Bondy, U.S. Ambassador to Bahrain, and a delegation including Mr Nathanael Lynn, Chief of the Public Affairs Section, Ms Samar Hasan, Education Specialist, and Dr Fathima Nasmy, Physician, at its campus in Busaiteen.
Welcoming the delegation, Professor Sameer Otoom, President of RCSI Medical University of Bahrain, and members of the University's Executive Committee, provided a guided viewing of the University's New Academic Building currently under construction - a significant development set to enhance the student experience.
The meeting commenced with an overview by Mr Stephen Harrison-Mirfield, Managing Director, detailing the University's history, relationship with partner hospitals and strategic direction.
A key focus of the meeting was the University's robust academic and clinical collaborations with leading US universities and hospitals. Mr Fadi Ghosn, Head of Recognition, Careers & Alumni, provided details on student research and clinical electives through such partnerships with prestigious institutions such as Johns Hopkins University, Yale University, the University of Alabama at Birmingham, the University of Tennessee Health Science Centre, Penn State College of Medicine and George Washington University.
As a result of this collaboration, 224 graduates of RCSI Medical University of Bahrain — including 117 American nationals — are now practising in the United States, a testament to the University's rigorous international standards and worldclass training it provides.
During the meeting, the delegation also explored potential federal funding opportunities for American nationals to study at the University, further expanding the collaboration between the University and U.S. institutions and demonstrating a shared commitment to advancing medical education and research.
Steven C. Bondy, stated, 'Its partnerships with leading U.S. universities and hospitals are expanding opportunities for clinical training, research, and student exchange. These efforts deepen the educational ties between the United States and Bahrain while advancing global healthcare.'
Commenting on the visit, Professor Otoom stated, 'RCSI Medical University of Bahrain extends its sincere thanks to His Excellency Steven C. Bondy, U.S. Ambassador to the Kingdom of Bahrain and the delegation for their visit, which highlights the strategic importance of our collaborative partnerships with esteemed U.S. institutions. These partnerships are crucial to our mission of providing students with a world-class medical education, fostering invaluable international exchange in healthcare, and ultimately enhancing the quality of care both regionally and globally.'
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Gulf Insider
5 days ago
- Gulf Insider
COVID Vaccine Removed for Kids, Pregnant Women
On Tuesday, HHS Secretary Robert F. Kennedy Jr. delivered a historic course correction from the Biden-era vaccine alongside NIH Director Dr. Jay Bhattacharya and FDA Commissioner Dr. Marty Makary, Kennedy announced that COVID-19 vaccine recommendations for healthy children and pregnant women were officially removed from the CDC's immunization schedule. 'Hi, everybody. I'm Robert F. Kennedy, Jr., your HHS secretary. And I'm here today with NIH Director Dr. Jay Bhattacharya and FDA Commissioner Dr. Marty Makary. I couldn't be more pleased to announce that, as of today, the COVID vaccine for healthy children and healthy pregnant women has been removed from the CDC recommended immunization schedule.' It was an unmistakable shift away from coercive one-size-fits-all medicine, and a clear signal that data, not politics, is now leading the conversation. On Tuesday, HHS Secretary Robert F. Kennedy Jr. delivered a historic course correction from the Biden-era vaccine policy. Standing alongside NIH Director Dr. Jay Bhattacharya and FDA Commissioner Dr. Marty Makary, Kennedy announced that COVID-19 vaccine recommendations for… — The Vigilant Fox 🦊 (@VigilantFox) June 1, 2025 Today, Dr. Marty Makary took the fight straight into the lion's den—appearing on CBS to dismantle the network's go-to vaccine talking points. When host Margaret Brennan tried to paint the updated guidance as confusing, Makary didn't flinch. 'Can you clearly state what the policy is? Because this is confusing,' she asked. Makary responded without hesitation: 'Yeah, we believe the recommendation should be with a patient and their doctor.' That's when the real shift came into focus. 'So we're going to get away from these blanket recommendations in healthy young Americans.' 'On the COVID vaccine schedule, we don't want to see kids kicked out of school because a 12-year-old girl is not getting her fifth COVID booster shot.' 'We don't see the data there to support a young, healthy child getting a repeat infinite annual COVID vaccine.' He then laid out the sheer absurdity of where the old policy was heading. 'There's a theory that we should sort of blindly approve the new COVID boosters in young, healthy kids every year in perpetuity, and a young girl born today should get 80 COVID mRNA shots or other COVID shots in her average lifespan.' 'We're saying that's a theory, and we'd like to check in and get some randomized controlled data. It's been about four years since the original randomized trials. So we'd like an evidence based approach.' And then came the knockout line—delivered with facts no one could deny. 'That is a decision between a parent and their doctor—I don't know if you know these statistics, but 88% of American kids, their parents have said no to the COVID shot last season. So America, the vast majority of Americans are saying no.' Today, Dr. Marty Makary took the fight straight into the lion's den—appearing on CBS to dismantle the network's go-to vaccine talking host Margaret Brennan tried to paint the updated guidance as confusing, Makary didn't flinch.'Can you clearly state what the… — The Vigilant Fox 🦊 (@VigilantFox) June 1, 2025 Brennan tried to shift gears—falling back on CDC data to argue that even healthy kids remained at risk. 'So the CDC data said 41% of children aged 6 months to 17 years hospitalized with COVID between 2022 and 2024 did not have a known underlying condition. In other words, they looked healthy,' she said. 'And COVID was serious for them.' But Makary was ready. Calm and precise, he dismantled the claim with surgical clarity. 'So first of all, we know the CDC data is contaminated with a lot of false positives from incidental positive COVID tests with routine testing of every kid that walks in the hospital.' 'We know that data historically under the Biden administration did not distinguish being sick from COVID or an incidental positive COVID test.' He shared what he's heard from the people who actually run the ICUs in America. 'When you go to an ICU in America and you ask how many people are in the ICU that are healthy, that are sick with COVID? The answer I get again, again is we haven't seen that in a year or years.' That's why, he warned, making universal recommendations based on flawed data isn't just wrong—it's dangerous. 'And so the worst thing you can do in public health is to put out an absolute universal recommendation in young, healthy kids.' 'And the vast majority of Americans are saying, no, we want to see some data. And you say, forget about the data, just get it anyway.' Brennan tried to shift gears—falling back on CDC data to argue that even healthy kids remained at risk.'So the CDC data said 41% of children aged 6 months to 17 years hospitalized with COVID between 2022 and 2024 did not have a known underlying condition. In other words, they… — The Vigilant Fox 🦊 (@VigilantFox) June 1, 2025 But it was the final exchange that landed like a sledgehammer. When Brennan questioned why the HHS bypassed the CDC's Advisory Committee on Immunization Practices (ACIP) for the new policy shift, Makary landed a haymaker. 'That panel has been a kangaroo court where they just rubberstamp EVERY single vaccine put in front of them.' He said the committee hadn't been focused on science, but on messaging and marketing. 'You look at the minutes of the last couple of years, they say, we want a simple message for everybody just so they can understand it. It was not a data based conversation. It was a conversation based on marketing and ease.' And without real evidence, he warned, these recommendations become little more than guesswork. 'If there's zero clinical data, you're opining. I mean—it's a theory.' 'And so we don't want to put out an absolute recommendation for kids, with no clinical data to support it.' The implication was unmistakable: public health decisions should be based on evidence and transparency—not rubber stamps and slogans. For the first time in years, someone on national television was calling out the system. But it was the final exchange that landed like a Brennan questioned why the HHS bypassed the CDC's Advisory Committee on Immunization Practices (ACIP) for the new policy shift, Makary landed a haymaker.'That panel has been a kangaroo court where they just… — The Vigilant Fox 🦊 (@VigilantFox) June 1, 2025 Also read: Moderna Disables Comments On X Post Announcing New Covid Shot Amid Backlash
Biz Bahrain
5 days ago
- Biz Bahrain
RCSI Medical University of Bahrain Expands Research and Clinical Training Partnerships with Leading Academic and Healthcare Institutions in Thailand
The Royal College of Surgeons in Ireland (RCSI) – Medical University of Bahrain has taken a significant step in advancing its international outlook by formalising a new partnership with the Faculty of Medicine Ramathibodi Hospital, Mahidol University in Bangkok, Kingdom of Thailand, as part of its ongoing commitment to expanding international academic and clinical collaboration. On May 23rd, a Memorandum of Understanding (MoU) was signed by Professor Sameer Otoom, President of RCSI Medical University of Bahrain, and Clinical Professor Artit Ungkanont, M.D., Dean of the Faculty of Medicine Ramathibodi Hospital. The agreement facilitates our students' participation in clinical and research electives across a broad range of medical specialities at Ramathibodi Hospital and opens the door to future collaboration in academia, exchange and joint initiatives. Professor Ungkanont, commented on the agreement: 'We believe that through this collaboration, both institutions will grow stronger—by learning from each other, sharing resources and supporting one another in the pursuit of global health equity and the development of future healthcare leaders.'This landmark agreement was part of a wider strategic visit to the Kingdom of Thailand, during which the University delegation also held high-level discussions with Associate Professor Dr Taveesin Tanprayoon, Chief Medical Officer, and Ms Artirat Charukitpipat, Chief Executive Officer of Bumrungrad International Hospital in Bangkok. Discussions focused on establishing clinical elective opportunities in cardiology and exploring avenues for collaborative research in key areas such as diabetes, obesity, cardiovascular diseases and genomics. Commenting on the significance of the partnership, Professor Otoom stated: 'The MoU with Ramathibodi Hospital, Mahidol University, and our productive discussion with leading healthcare institutions in Thailand represent an important milestone in our mission to provide world-class clinical and research opportunities for our students. These efforts reflect RCSI Medical University of Bahrain's commitment to academic excellence, global health engagement, and the advancement of medical education through strategic international alliances. These developments follow the recent visit of His Excellency Sumate Chulajata, Ambassador of the Kingdom of Thailand to the Kingdom of Bahrain, to the University campus. During that meeting, held earlier in May, the University outlined its intention to strengthen ties with Thai institutions through formal partnerships and mutual engagement. Further reinforcing this strategic direction, RCSI Medical University of Bahrain participated in the International Diabetes Federation (IDF) World Diabetes Congress 2025 in Thailand in April. A group of faculty and students contributed actively to scientific discussions and presented impactful research findings, highlighting the importance of regular ophthalmologic screening for pre-diabetic patients. Their research revealed that signs of diabetic retinopathy may be evident at HbA1c levels between 5.7% and 6.4%, a lower threshold than previously assumed. As RCSI Medical University of Bahrain continues to strengthen its network of global partners, the University remains focused on enhancing the academic experience and clinical training of its students, while fostering impactful research that addresses global health challenges.
Daily Tribune
29-05-2025
- Daily Tribune
Half of Elderly Patients Prescribed Risky Medications, Study Finds
TDT | Manama Professor Tom Fahey, a leading expert in general practice and epidemiology, presented critical findings on the safety and appropriateness of medication use in elderly populations during the Bahrain International Conference on Family Medicine and Primary Healthcare, held at the Gulf Hotel Bahrain. Drawing from extensive Irish research, Prof. Fahey outlined trends in potentially inappropriate prescribing and adverse drug reactions, with a particular focus on patients aged 70 and above. His presentation was based on data from a large cohort study involving over 50,000 patients in the Dublin area, highlighting how hospital admission, both elective and emergency, were significantly associated with the likelihood of receiving high-risk medications. Prof. Fahey emphasized the risks of polypharmacy, the simultaneous use of multiple medications—particularly among elderly patients, linking it to increased emergency visits, hospitalizations, and functional decline. In a six-year observational study across 15 general practices in Dublin, a significant number of elderly patients experienced ADRs, with over 10% requiring emergency hospitalization. The most commonly implicated drugs were NSAIDs and certain psychoactive medications. The research also investigated the rise in the use of strong opioids, such as morphine and fentanyl, which increased from 20% to 43% over a 15-year period. Prof. Fahey warned that these drugs carry well-documented risks, particularly in older populations, mirroring concerns across other European and American healthcare systems. Another area of concern was the prescribing of medications affected by alcohol consumption. Interventions aimed at reducing alcohol-medication interactions showed modest success, though the impact on long-term health outcomes remained limited. Prof. Fahey concluded by stressing the urgent need for policy interventions, better prescribing practices, and clinical guidelines to mitigate medication-related harm in aging populations. He called for family physicians and primary healthcare providers to play a leading role in addressing inappropriate medication use and improving patient safety. - Hospitalization was a major factor associated with increased exposure to risky medications, independent of other health conditions.
